Selecting and advancing drug candidates through discovery and development is a long, resource-intensive process. Demonstrating efficacy, mechanism of action (MOA), and product quality requires robust ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Newswise — HOUSTON, Dec. 3, 2025 /PRNewswire/ -- Avance Biosciences today announced the opening of its new Potency and Cell-Based Assay Center of Excellence, a purpose-built facility designed to ...

CellCarta and Imagene AI today announced an expanded collaboration to provide a coordinated path for biopharma companies to validate, deploy, and scale AI-powered biomarker and companion diagnostic ...

SPT Labtech, a global leader in innovative laboratory automation, today announced a strategic collaboration with Semarion, a University of Cambridge spin-out company from the Cavendish Laboratory ...

Cell surface protein labeling supports precise characterization of immune checkpoints, receptors, and other therapeutic ...

CAR-T-cell therapy has shown remarkable promise in addressing unmet medical needs in people with cancer. Continued progress in this field will depend, in part, on the advancement of frameworks for ...

Drug-induced seizures remain one of the most disruptive safety failures in modern pharmaceutical research, derailing ...

Flow-based CBA platform solutions deliver flexible, high-performance tools for global life-science research HUSTON, TX, ...

TELO-MRD is a type of liquid-biopsy applied to finding Minimal Residual Disease (MRD) in samples of peripheral blood. It combines enumeration of circulating tumor cells ("CTCs"), specifically ...

Avance Biosciences opened its new Potency and Cell-Based Assay Center of Excellence, a purpose-built facility designed to expand and centralize the company’s capabilities in potency and functional ...